Background: The indications for Below-Knee Amputation (BKA) are expansive and etiologic subgroups are not well defined. This analysis uses primary ICD-10 diagnosis codes to stratify patients undergoing BKA, and examines differences in subgroup characteristics and 30-day outcomes.
Methods: We performed a retrospective analysis of patients in the NSQIP database who underwent BKA between 2015 and 2020. Approximately 80% of the 12,157 NSQIP BKA entries with primary ICD-10 diagnosis codes were stratified to diabetic ( = 3,363), vascular ( = 3,632), or infectious ( = 2,743) etiological subgroups.
Results: Patients with vascular etiologies were older, more likely to be female, underweight, ASA classification of four, and active tobacco users than patients in the other groups. Across all groups, there were incidences of 37.5% for 30-day inpatient complications, 7.0% for Clavien-Dindo Grade IV 30-day complications, 10.2% for 30-day readmission, and 4.2% for 30-day mortality. On bivariate analysis, infectious patients had the highest incidences of inpatient complications (38.6%, = 0.030) and Clavien-Dindo Grade IV complications (7.8%, = 0.055). Patients in the vascular group had the highest rates of readmission (12.7%, <0.001) and mortality (4.9%, = 0.006). In multivariate analysis, infectious etiology was an independent risk factor for 30-day mortality with an odds ratio of 1.48 (1.11-19.6, = 0.007).
Conclusions: Despite significant clinical overlap of diabetic, vascular, and infectious etiologies of BKA, this study demonstrates that these patients can be grouped by primary ICD-10 code with statistically significant differences in patient characteristics and 30-day outcomes. Further delineation by etiology could focus clinical and research efforts.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11749917 | PMC |
http://dx.doi.org/10.1016/j.sipas.2023.100159 | DOI Listing |
Oncoscience
January 2025
McGill Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada.
Importance: Cervical cancer is the fourth most common cancer among women globally and a significant cause of cancer-related deaths. Understanding the impact of cervical cancer diagnosed during pregnancy on maternal, delivery, and neonatal outcomes is crucial for improving clinical management and outcomes for affected women and their children.
Objective: To determine the effects of cervical cancer diagnosed during pregnancy on maternal, delivery, and neonatal outcomes using a population based, American database.
Front Cell Infect Microbiol
January 2025
College of Veterinary Medicine, Henan Agricultural University, Zhengzhou, China.
Background: Sheep coccidiosis could disturb the balance of intestinal microbiota, causing diarrhea, and even death in lambs. Chemical drugs are the primary method of treating sheep coccidiosis, but their use will bring drug resistance, toxic side effects, drug residues, and other problems. Chinese herbal medicines are investigated as alternative methods for controlling coccidian infections.
View Article and Find Full Text PDFCirc Cardiovasc Interv
January 2025
Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA (C.L., A.T., Y.S., J.S., R.W.Y.).
Background: Food and Drug Administration-mandated postmarket studies for transcatheter aortic valve replacement in low-risk populations plan to use passively collected registry data linked to claims for long-term follow-up out to 10 years. Therefore, it is critically important to understand the validity of these claims-based end points. We sought to evaluate the ability of administrative claims with () codes to identify trial-adjudicated end points and reproduce treatment comparisons of aortic valve replacement in the Evolut Low Risk Trial.
View Article and Find Full Text PDFJ Clin Psychiatry
January 2025
Division of Gastrointestinal and Liver Diseases, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.
We compared substance use disorder (SUD) prevalence among adult inflammatory bowel disease (IBD) hospitalizations with non-IBD controls from the 2016-2018 National Inpatient Sample, assessing correlations with demographics, socioeconomic status, geographic regions, depression, and anxiety. The primary aim focused on SUD, defined as substance abuse or dependence (: F10-F19) excluding unspecified use or remission, among hospitalizations documenting IBD (Crohn's disease or ulcerative colitis; : K50-51) as one admitting diagnosis (IBD-D). The prevalence of SUD among hospitalizations with and without IBD was compared.
View Article and Find Full Text PDFJ Cachexia Sarcopenia Muscle
February 2025
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Background: Cachexia is a frequent companion of chronic diseases and a well-established predictor of poor patient performance and outcome. Since cachexia as a discharge diagnosis is not much investigated, we aimed to investigate prevalence of cachexia in hospitalised patients and their outcome.
Methods: We conducted a retrospective analysis of the National Hospital Health Care Statistics Database using the 10th revision of the International Classification of Diseases codes.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!